Sun et al. have observed that metformin partially acts through a B. fragilis-bile acid glycoursodeoxycholic acid (GUDCA)-intestinal farnesoid X receptor (FXR) axis to improve metabolic dysfunction, such as hyperglycemia [68]. This evidence concerns the gene NR1H4 and Hyperglycemia.